John Hathaway - Dec 31, 2024 SCHEDULE 13G Report for Medicus Pharma Ltd. Common shares, no par value (MDCX)

Filing Manager: Hathaway John Jason
Reporting Manager: John Hathaway
Security: Medicus Pharma Ltd. Common shares, no par value
Symbol: MDCX
Shares outstanding: 11.8M shares
Disclosed Ownership: 801K shares
Ownership: 6.8%
Form type: SCHEDULE 13G
Date filed: 2/10/2025, 10:51 AM
Date of event: Dec 31, 2024
Next filing: Aug 12, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
John Hathaway	6.8%	801K	801K	0	/s/ John Hathaway	John Hathaway
SkinJect Partners LLC	6.8%	801K	801K	0	/s/ John Hathaway	John Hathaway, Managing Director